Actinogen Medical Limited (ASX:ACW)

Actinogen Medical Revenue

In the fiscal year ending June 30, 2026, Actinogen Medical had annual revenue of 12.67M AUD with 130.87% growth. Actinogen Medical had revenue of 10.80M in the half year ending June 30, 2026, with 19.70% growth.

• Revenue: 12.67M
• Revenue Growth: +130.87%
• P/S Ratio: 17.02
• Revenue / Employee: 2.11M
• Employees: 6
• Market Cap: 215.72M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	12.67M	7.18M	130.87%
Jun 30, 2025	5.49M	-4.44M	-44.73%
Jun 30, 2024	9.93M	5.04M	103.18%
Jun 30, 2023	4.89M	1.25M	34.28%
Jun 30, 2022	3.64M	1.66M	83.47%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error